Medtronic (MDT) Gross Profit (2014 - 2026)

Medtronic (MDT) has 13 years of Gross Profit data on file, last reported at $6.4 billion in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 10.88% year-over-year to $6.4 billion; the trailing twelve-month figure through Apr 2026 stood at $23.6 billion (up 7.93% YoY), and the FY2026 full-year result was $23.6 billion, up 7.93% from the prior year.
• Gross Profit rose to $6.4 billion in Q2 2026, from $5.8 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $6.4 billion in Q2 2026 to a low of $4.9 billion in Q3 2022.
• A 5-year average of $5.4 billion and a median of $5.5 billion in 2022 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit fell 9.91% in 2022 and climbed 10.88% in 2026, its largest moves.
• Tracing MDT's Gross Profit over 5 years: stood at $5.1 billion in 2022, then advanced by 3.43% to $5.2 billion in 2023, then gained by 4.48% to $5.5 billion in 2024, then grew by 8.12% to $5.9 billion in 2025, then gained by 8.63% to $6.4 billion in 2026.
• Business Quant data shows MDT's Gross Profit at $6.4 billion in Q2 2026, $5.8 billion in Q1 2026, and $5.9 billion in Q4 2025.